Home / Inspections / 1004544

FDA Inspection 1004544 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1035346

The FDA completed an inspection of Octapharma Plasma, Inc. on January 26, 2017 in Jacksonville, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 26, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Jacksonville, FL (United States)

Facility

Other inspections at this facility

  • 1255733 (NAI Thu Nov 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1090929 (NAI Wed Apr 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 902074 (NAI Wed Oct 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 792075 (NAI Thu Jul 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 767449 (NAI Thu Feb 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources